Bank of America’s Regulus Therapeutics RGLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-29,937
Closed -$52.4K 8636
2025
Q1
$52.4K Sell
29,937
-23,904
-44% -$31.5K ﹤0.01% 6730
2024
Q4
$85.1K Sell
53,841
-586
-1% -$900 ﹤0.01% 6462
2024
Q3
$85.5K Buy
54,427
+21,371
+65% +$35.4K ﹤0.01% 6392
2024
Q2
$59K Buy
+33,056
New +$76.7K ﹤0.01% 6469
2024
Q1
Sell
-11
Closed -$14 8108
2023
Q4
$14 Buy
+11
New +$15 ﹤0.01% 7726
2023
Q1
Sell
-18
Closed -$24 8196
2022
Q4
$24 Buy
+18
New +$28 ﹤0.01% 7950
2022
Q3
Sell
-1,001
Closed -$2K 8136
2022
Q2
$2K Buy
+1,001
New +$2.43K ﹤0.01% 7794
2021
Q4
Sell
-39,331
Closed -$271K 8569
2021
Q3
$271K Buy
39,331
+18,912
+93% +$139K ﹤0.01% 6087
2021
Q2
$166K Sell
20,419
-28,507
-58% -$318K ﹤0.01% 6216
2021
Q1
$764K Buy
+48,926
New +$724K ﹤0.01% 5045
2020
Q2
Sell
-64
Closed 7087
2020
Q1
$0 Buy
+64
New +$558 ﹤0.01% 7187
2019
Q1
Sell
-46
Closed 7367
2018
Q4
$0 Buy
+46
New +$762 ﹤0.01% 7339
2018
Q1
Sell
-3
Closed 7309
2017
Q4
$0 Sell
3
-30
-91% -$3.8K ﹤0.01% 7211
2017
Q3
$5K Buy
33
+31
+1,550% +$3.9K ﹤0.01% 6736
2017
Q2
$0 Sell
2
-55
-96% -$9.18K ﹤0.01% 7132
2017
Q1
$11K Sell
57
-14
-20% -$2.67K ﹤0.01% 6519
2016
Q4
$19K Buy
71
+57
+407% +$18.5K ﹤0.01% 6361
2016
Q3
$5K Sell
14
-32
-70% -$13.2K ﹤0.01% 6613
2016
Q2
$16K Sell
46
-115
-71% -$82.4K ﹤0.01% 6338
2016
Q1
$134K Sell
161
-88
-35% -$70K ﹤0.01% 5346
2015
Q4
$261K Buy
249
+247
+12,350% +$248K ﹤0.01% 5211
2015
Q3
$2K Sell
2
-409
-100% -$420K ﹤0.01% 6975
2015
Q2
$540K Buy
411
+410
+41,000% +$662K ﹤0.01% 4638
2015
Q1
$2K Sell
1
-32
-97% -$69.5K ﹤0.01% 6704
2014
Q4
$63K Buy
+33
New +$58.7K ﹤0.01% 6191
2014
Q2
Sell
-11
Closed -$12K 8171
2014
Q1
$12K Sell
11
-119
-92% -$132K ﹤0.01% 7135
2013
Q4
$115K Buy
130
+129
+12,900% +$111K ﹤0.01% 6025
2013
Q3
$2K Sell
1
-40
-98% -$47.2K ﹤0.01% 7632
2013
Q2
$48K Buy
+41
New +$39K ﹤0.01% 6582

Other funds holding RGLS